2.32 USD
+0.04 (+1.75%)
At close: Jan 30, 2026
2.28 USD
-0.04 (-1.72%)
After Hours: 1/30/2026, 8:00:01 PM
Taking everything into account, DH scores 3 out of 10 in our fundamental rating. DH was compared to 35 industry peers in the Health Care Technology industry. DH has a bad profitability rating. Also its financial health evaluation is rather negative. DH is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- DH had positive earnings in the past year.
- In the past year DH had a positive cash flow from operations.
- DH had negative earnings in each of the past 5 years.
- Each year in the past 5 years DH had a positive operating cash flow.
1.2 Ratios
- DH's Return On Assets of -24.97% is in line compared to the rest of the industry. DH outperforms 45.71% of its industry peers.
- DH has a worse Return On Equity (-66.24%) than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.97% | ||
| ROE | -66.24% | ||
| ROIC | N/A |
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of DH (75.93%) is better than 82.86% of its industry peers.
- DH's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for DH so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
2. Health
2.1 Basic Checks
- DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, DH has less shares outstanding
- DH has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, DH has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -0.70, we must say that DH is in the distress zone and has some risk of bankruptcy.
- DH has a Altman-Z score (-0.70) which is in line with its industry peers.
- DH has a debt to FCF ratio of 4.64. This is a neutral value as DH would need 4.64 years to pay back of all of its debts.
- DH's Debt to FCF ratio of 4.64 is fine compared to the rest of the industry. DH outperforms 62.86% of its industry peers.
- DH has a Debt/Equity ratio of 0.56. This is a neutral value indicating DH is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.56, DH is doing worse than 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 4.64 | ||
| Altman-Z | -0.7 |
ROIC/WACCN/A
WACC9.09%
2.3 Liquidity
- DH has a Current Ratio of 1.60. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
- DH has a worse Current ratio (1.60) than 62.86% of its industry peers.
- A Quick Ratio of 1.60 indicates that DH should not have too much problems paying its short term obligations.
- DH has a Quick ratio of 1.60. This is in the lower half of the industry: DH underperforms 62.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.6 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
- The earnings per share for DH have decreased strongly by -20.59% in the last year.
- DH shows a decrease in Revenue. In the last year, the revenue decreased by -5.30%.
- Measured over the past years, DH shows a very strong growth in Revenue. The Revenue has been growing by 24.15% on average per year.
EPS 1Y (TTM)-20.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-4.23%
3.2 Future
- DH is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.46% yearly.
- Based on estimates for the next years, DH will show a decrease in Revenue. The Revenue will decrease by -1.82% on average per year.
EPS Next Y-28.57%
EPS Next 2Y-12.83%
EPS Next 3Y-5.46%
EPS Next 5YN/A
Revenue Next Year-4.42%
Revenue Next 2Y-3.31%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 8.59, which indicates a very decent valuation of DH.
- Compared to the rest of the industry, the Price/Earnings ratio of DH indicates a rather cheap valuation: DH is cheaper than 97.14% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.32, DH is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 8.72, the valuation of DH can be described as reasonable.
- DH's Price/Forward Earnings ratio is rather cheap when compared to the industry. DH is cheaper than 94.29% of the companies in the same industry.
- DH is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.59 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
- DH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DH is cheaper than 100.00% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of DH indicates a rather cheap valuation: DH is cheaper than 97.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.66 | ||
| EV/EBITDA | 3.12 |
4.3 Compensation for Growth
- DH's earnings are expected to decrease with -5.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.83%
EPS Next 3Y-5.46%
5. Dividend
5.1 Amount
- No dividends for DH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DEFINITIVE HEALTHCARE CORP / DH FAQ
Can you provide the ChartMill fundamental rating for DEFINITIVE HEALTHCARE CORP?
ChartMill assigns a fundamental rating of 3 / 10 to DH.
Can you provide the valuation status for DEFINITIVE HEALTHCARE CORP?
ChartMill assigns a valuation rating of 7 / 10 to DEFINITIVE HEALTHCARE CORP (DH). This can be considered as Undervalued.
Can you provide the profitability details for DEFINITIVE HEALTHCARE CORP?
DEFINITIVE HEALTHCARE CORP (DH) has a profitability rating of 3 / 10.
What are the PE and PB ratios of DEFINITIVE HEALTHCARE CORP (DH) stock?
The Price/Earnings (PE) ratio for DEFINITIVE HEALTHCARE CORP (DH) is 8.59 and the Price/Book (PB) ratio is 0.84.